Why Nike Beat Earnings But Dropped 9% (Rating Upgrade)

Nike's revenues fell ~3% YoY at constant currency (FX masked the headline), with notable weakness across EMEA and China indicating deteriorating demand. Gross margin held better-than-expected at 40.2%, but cannot offset falling volumes, a ~$1.0B footwear gap versus FY24, and ongoing pressure from tariffs and unfavorable mix. The company still trades at a premium despite missing growth, leaving the stock near fair value with limited upside and an unproven turnaround.

Analysis

Nike’s current weakness creates asymmetric opportunities across channels and competitors. North American DTC and premium athleisure players that can maintain inventory discipline (lower promotional cadence, tighter allocation) will win share from mass-market tiers if Nike leans into promotions; expect Lululemon to be the primary beneficiary in urban/high-income cohorts while value players like Skechers pick up share in price-sensitive segments.

On the supply side, lower footwear shipments will depress factory utilization in Southeast Asia; expect shorter lead times to reverse bargaining power toward retailers and larger OEM consolidators, pressuring small suppliers and pushing incremental working capital volatility across footwear supply chains over the next 3–12 months. Tariff and FX noise raises execution risk — a stronger dollar or additional tariff actions would amplify markdowns and force more aggressive wholesale clearance, turning an earnings miss into a two-quarter margin squeeze.

Valuation and investor positioning are the choke points for any re-rate: the stock will need demonstrable stabilization in end-market demand (China/EMEA) or clearer margin durability from structural cost saves to justify a move higher. Near-term catalysts that could rerate the story are binary — a tangible China demand recovery or a management commitment to reallocate capital (slower buybacks, faster margin reinvestment) — while downside catalysts include a renewed markdown cycle or adverse tariff/fx moves that materialize within 1–4 quarters.

Key Decisions for Investors

• Short NKE via a 6–12 month put spread (buy 1 put ~10–20% OTM, sell lower strike to finance) sized ~1–2% portfolio: entry on any post-earnings bounce. Thesis: demand/distribution pain and potential markdown cycle drive ~20–30% downside to consensus comps within 6–12 months; reward ~3:1 vs defined premium loss if recovery shows up sooner.
• Pair trade — short NKE / long LULU equal notional for 3–9 months: express share shift to premium athleisure and superior inventory discipline. Target relative outperformance of 15–25%; cap losses by watching same-store sales crossovers and China commentary.
• Go long SKX (Skechers) 3–12 month for a tactical consumer downtrade play: smaller ticket, value-oriented shoes should outpace when consumers trade down. Position size 0.5–1% with a 20–30% upside target and stop-loss at 10% to protect vs broad discretionary rebounds.
• Hedge macro/FX tail risk: if running a larger NKE short, buy USD-Asia or USD-emerging market exposure or enter currency-hedged equity shorts for 3–6 months to protect vs sudden FX reversals that would temporarily mask demand weakness. This reduces scenario-specific gamma risk from currency-driven earnings noise.